// App-Quantinova.ai

: Comparison of Dexamethasone Versus Prednisolone Prephase in Induction Therapy of Pediatric Acute Lymphoblastic Leukemia: A Single-Center, Randomized Controlled Study from India

Researchers

Presenter

  • Anamika Bakliwal

Principal Investigators

  • Jatin Munjal

  • Rituparna Chetia

  • Debranjani Chattopadhyay

  • Sudeep Vaniyath

  • Ashok K Rajoreya

  • UTTAM KUMAR NATH

Medical Centers

  • DEPARTMENT OF HEMATO-ONCOLOGY & BMT, VENKATESHWAR HOPSITAL, NEW DELHI, NEW DELHI, India

  • Department of Medical Oncology and Hematology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India

  • NATIONAL REFERENCE LABORATORY, LAL PATH LAB, LAL PATH LAB, NEW DELHI, NEW DELHI, India

  • Hematology, All Inida Institute of Medical Sciences, Rishikesh, Uttarakhand, India

  • All India Institute of Medical Sciences (AIIMS), Rishikesh, Rishikesh, India

  • All India Institute of Medical Sciences (AIIMS),Guwahati, All India Institute of Medical Sciences (AIIMS), Rishikesh, GUWAHATI, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisolone

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

  • Single Center

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved